MTHRY
M3, Inc.

M3, Inc.MTHRY

Healthcare · Health Information Services
5.69USD
-3.40%
Nov 09, 2026
MTHRY overview ready
Operator of Physician-Focused Digital Platforms for Pharma Marketing and Clinical Support
M3 operates large physician-facing digital platforms and monetizes those networks through pharmaceutical marketing and research services, clinical-development and site-support activities, patient recruitment, decentralized-trial support, and healthcare-professional recruitment.
Theme not measured
No economic group is assigned yet.
Constructive pullback in an uptrend
Longer-term context reads early recovery, with a near-term setup of constructive pullback.
The setup is constructive, but the underlying structure is still poor.
Attractive valuation
Current market expectations look undemanding relative to the strength of its balance sheet.
Fundamentals not measured
Primary risk
Regulatory changes impacting digital healthcare marketing.
Market Nov 6Price action Nov 8Research Oct 25

Conviction Level

Theme Momentum has no canonical measurement for this company — a research-profile dimension, not an input to this score.

PriceAction7.1BusinessPerformance—BusinessQuality—Valuation8.2ThemeMomentum—Business Performance not yet available.

Conviction uses Price Action, Business Performance, Business Quality, Valuation. Theme Momentum is research context, not an input.

Theme momentumPrimary theme · group context, not entry timing
No economic group yet — pending research
Price
Loading price history…

Price Action

Constructive pullback in an uptrend
Longer-term context reads early recovery, with a near-term setup of constructive pullback.
The setup is constructive, but the underlying structure is still poor.
EntryReset + recovery

The stock is still rebuilding below its long-term weekly base, and the recent reset toward the daily SMA200 aligned with support at the weekly EMA21. Daily structure is recovering above the fast averages, improving the current entry location.

Key Financials

Market Cap
$7.7B
Provider figure at the stated date
Avg Volume (60D)
115.6K
60 sessions
Revenue Growth YoY
+8.3%
Latest quarter
Gross Margin
+49.5%
Trailing twelve months
Operating Margin
+19.4%
Trailing twelve months
Distance from 200DMA
+7.2%
P/E
25.9x
Provider figure at the stated date
Market metrics as of Nov 7, 2026

Business Performance

Business Quality

Not assessed

Not assessed — the company is no longer an active, independent filer.

Fundamentals & Valuation

Only one valuation perspective could be built for this company, and it reads cheap.
M3, Inc. has a Cheap valuation stance because current market expectations look undemanding relative to the strength of its balance sheet. That rests on revenue growing 8%, a 19% operating margin and a 49% gross margin.

Company Research

Thesis
M3 operates large physician-facing digital platforms and monetizes those networks through pharmaceutical marketing and research services, clinical-development and site-support activities, patient recruitment, decentralized-trial support, and healthcare-professional recruitment.
Opportunity
Moderate opportunity
Pharmaceutical and biotech spending on verified healthcare-professional and patient networks, digital engagement, market intelligence, and recruitment infrastructure to improve commercial outreach and clinical-study execution.
Key risk
Regulatory changes impacting digital healthcare marketing.

Economic classification

Loading the economic classification…

Business & Markets

Healthcare · Health Information Services
What they do

M3, Inc. operates online platforms providing medical information, tools, and services to physicians and healthcare professionals, supporting clinical trials, research, and recruitment activities.

How it earns

The company generates revenue primarily through subscription and project-based fees from pharmaceutical marketing, clinical research support, and recruitment services.

Products & services
M3.com physician information platform
MR-kun medical information delivery
QOL-kun marketing support
M3.com CAREER physician recruitment
Yakucari pharmacist job search
Online lectures
Clinical trial and research support
Customers & end markets
Physicians and healthcare professionals
Pharmaceutical and biotech companies
Clinical research organizations
Market position

Leader in physician-facing digital platforms and healthcare professional network monetization in Japan.

Demand drivers
Low cyclicality

Demand for medical information and clinical research support is relatively stable and less sensitive to economic cycles.